$77.36 1.1%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 337 -3.2%
Sentiment 96 0%
Webpage traffic 577,000 3.2%
Employee Rating 78 0%
Google Adspend $40,739 N/A
Google Trends 12 -78.6%
Linkedin Employees 14,391 N/A
Lobbying Cost $797,000 0%
NPS 19 -9.5% N/A
Patents 489 0.2%
4chan Mentions 0%
Facebook Engagement 35 2.9%
Facebook followers 23,055 0%
Stocktwits Mentions 12 20%
Stocktwits Subscribers 76,064 0%
Twitter Followers 73,883 0%
Youtube Subscribers 5,120 0%
Instagram Followers N/A N/A
News Mentions -100%
Reddit Mentions 1 0%
ESG 82 0%
Business outlook 70 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Gilead Sciences

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

Gilead Sciences
Price $77.36
Target Price Sign up
Market Cap $93.7B
Dividend Yield 0.0399
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '236.82B3.48B3.34B2.18B3.16B
Q2 '236.42B3.89B2.53B1.05B2.42B
Q1 '236.12B3.27B2.85B1.01B2.1B
Q4 '227.16B4.09B3.07B1.64B2.76B
Q3 '226.82B3.05B3.77B1.79B3.11B

Insider Transactions

Dickinson Andrew D filed to sell 104,003 shares at $80.
October 18 '23
Parsey Merdad filed to sell 70,130 shares at $77.
September 13 '23
Dickinson Andrew D filed to sell 107,587 shares at $80.
July 21 '23
Parsey Merdad filed to sell 29,402 shares at $76.9.
June 14 '23
Parsey Merdad filed to sell 70,130 shares at $79.
March 14 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.